KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Guardant Health (GH) Net Income towards Common Stockholders (2017 - 2025)

Historic Net Income towards Common Stockholders for Guardant Health (GH) over the last 9 years, with Q3 2025 value amounting to -$92.7 million.

  • Guardant Health's Net Income towards Common Stockholders rose 1394.75% to -$92.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$398.8 million, marking a year-over-year increase of 2217.38%. This contributed to the annual value of -$436.4 million for FY2024, which is 898.45% up from last year.
  • As of Q3 2025, Guardant Health's Net Income towards Common Stockholders stood at -$92.7 million, which was up 1394.75% from -$99.9 million recorded in Q2 2025.
  • Guardant Health's Net Income towards Common Stockholders' 5-year high stood at -$72.8 million during Q2 2023, with a 5-year trough of -$229.4 million in Q2 2022.
  • Moreover, its 5-year median value for Net Income towards Common Stockholders was -$107.8 million (2024), whereas its average is -$119.2 million.
  • Its Net Income towards Common Stockholders has fluctuated over the past 5 years, first plummeted by 29546.32% in 2021, then surged by 6828.21% in 2023.
  • Over the past 5 years, Guardant Health's Net Income towards Common Stockholders (Quarter) stood at -$90.9 million in 2021, then plummeted by 53.92% to -$139.9 million in 2022, then crashed by 33.67% to -$187.0 million in 2023, then soared by 40.65% to -$111.0 million in 2024, then grew by 16.47% to -$92.7 million in 2025.
  • Its Net Income towards Common Stockholders stands at -$92.7 million for Q3 2025, versus -$99.9 million for Q2 2025 and -$95.2 million for Q1 2025.